Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Trading Cabana -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (5440)	5/7/2009 3:03:29 PM
From: RockyBalboa	Respond to of 6370

Thanks, yes I also ventured into VNDA today since it was showing $12 pre hours. Here is an interesting YTD statistic of our loved dogs: seekingalpha.com by that list we must be in a raging bull market (but not in financials). Right? But the TBT seems to work, so far.

To: Kevin Podsiadlik who wrote (5440)	7/20/2009 8:59:30 AM
From: RockyBalboa	Respond to of 6370

Todays moonshot, HGSI, at mid 11, is now up about 24 times from march lows and 5x in a week alone. Either it is being acquired, or it does a secondary pretty fast to stabilise its balance sheet. it was sucked past its $9 gap with a vacuum cleaner. Every quarter dollar there were some like 100 shares asking. But at 12 the going gets tough. People will wisen up on the realistic expectations about revenue for the drug. With an enterprise value over 2B hgsi is likely fully valued. On the other hand: " Human Genome Sciences estimates there are 5 million lupus patients worldwide, and says Benlysta would be the first drug in decades approved for systemic lupus."